Medidata Achieves Top Ranking in Everest Group's PEAK Matrix® Evaluation for eCOA, Advancing the Future of Patient Experience
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Sep 05 2025
0mins
Source: Yahoo Finance
Medidata eCOA Recognition: Medidata has been named a Leader in Everest Group's 2025 PEAK Matrix® Assessment for Life Sciences eCOA Products, supporting over 1 million patients and significantly reducing study build timelines by up to 50%.
Innovative Solutions and Partnerships: The company continues to innovate with tools like Medidata Designer and partnerships such as with Cogstate, enhancing the clinical trial experience and data integrity, particularly in Central Nervous System trials.
Analyst Views on EG
Wall Street analysts forecast EG stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for EG is 368.07 USD with a low forecast of 252.67 USD and a high forecast of 491.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
12 Analyst Rating
4 Buy
8 Hold
0 Sell
Moderate Buy
Current: 321.700
Low
252.67
Averages
368.07
High
491.00
Current: 321.700
Low
252.67
Averages
368.07
High
491.00
About EG
Everest Group, Ltd. is a Bermuda-based global company engaged in underwriting activities. It provides property, casualty, and specialty reinsurance, and insurance products. The Company conducts its principal business through its Reinsurance and Insurance reportable segments. The Reinsurance Segment underwrites property and casualty reinsurance and specialty lines globally. It operates using both treaty and facultative reinsurance models. Treaty reinsurance involves covering a portfolio of risks under a pre-agreed arrangement, while facultative reinsurance provides coverage for individual risks that are negotiated separately. The Insurance segment underwrites property and casualty insurance and conducts its business through wholesale and retail brokers, surplus lines brokers, and program administrators. Its operations in more than 100 countries across six continents. The Company underwrites reinsurance through both brokers and direct arrangements with ceding companies.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
